|
2012 |
Mechanisms of Bv8-induced biphasic hyperalgesia: increased excitatory transmitter release and expression. |
Michael H. Ossipov, Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD |
|
2012 |
Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues. |
John M. Streicher, PhD |
|
2012 |
Selective oestrogen receptor modulators differentially potentiate brain mitochondrial function. |
Roberta Diaz Brinton, Ph.D |
|
2012 |
Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2012 |
Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis. |
Roberta Diaz Brinton, Ph.D |
|
2012 |
The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration. |
|
|
2012 |
Minireview: translational animal models of human menopause: challenges and emerging opportunities. |
Roberta Diaz Brinton, Ph.D |
|
2012 |
Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid. |
Roberta Diaz Brinton, Ph.D |
|
2012 |
The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid. |
|
|
2012 |
A dominant negative ERβ splice variant determines the effectiveness of early or late estrogen therapy after ovariectomy in rats. |
Roberta Diaz Brinton, Ph.D |
|
2012 |
Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2011 |
Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands. |
Peg Davis, Victor Hruby, Ph.D., Josephine Lai , Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD, Eva Varga, Ph.D. |
|
2011 |
Estrogen receptor β-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause. |
Roberta Diaz Brinton, Ph.D |
|
2011 |
17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. |
Roberta Diaz Brinton, Ph.D |
|
2011 |
Hippocampal responsiveness to 17β-estradiol and equol after long-term ovariectomy: implication for a therapeutic window of opportunity. |
Roberta Diaz Brinton, Ph.D |
|
2011 |
Estrogen protection against mitochondrial toxin-induced cell death in hippocampal neurons: antagonism by progesterone. |
Roberta Diaz Brinton, Ph.D |
|
2011 |
The effect of dietary soy isoflavones before and after ovariectomy on hippocampal protein markers of mitochondrial bioenergetics and antioxidant activity in female monkeys. |
Roberta Diaz Brinton, Ph.D |
|
2011 |
Membrane estrogen receptors mediate calcium signaling and MAP kinase activation in individual hippocampal neurons. |
Roberta Diaz Brinton, Ph.D |
|
2011 |
Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2011 |
Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain. |
John M. Streicher, PhD |
|
2011 |
Intrathecal PKA-selective siRNA treatment blocks sustained morphine-mediated pain sensitization and antinociceptive tolerance in rats. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2011 |
The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). |
Roberta Diaz Brinton, Ph.D |
|
2011 |
Development of potent μ and δ opioid agonists with high lipophilicity. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2011 |
Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function. |
Roberta Diaz Brinton, Ph.D |
|
2011 |
Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions. |
Roberta Diaz Brinton, Ph.D |
